Nuclear factor translocation and acute anterior uveitis.
OBJECTIVE
To investigate the roles of activation of macrophages isolated from C3H/HeN and C3H/HeJ mice and stimulated by lipopolysaccharide (LPS), and toll-like receptor 4-mediated signal transduction in the development of acute anterior uveitis.


METHODS
Establish animal models with acute anterior uveitis by intraperitoneal injection of vibrio cholera endotoxin into C3H/HeN mice (wild type) and C3H/HeJ mice (toll-like receptor 4 (TLR4) gene defection type). Peritoneal macrophages were obtained from C3H/HeN and C3H/HeJ mice. Immunofluorescence staining was used to identify the F4/80+ positive cells (iris, peritoneal macrophages) and to observe the expression of TLR4, myeloid differentiation factor 88 (MyD88), and nuclear factor kappa B (NF-κB), with or without LPS (1 μg/ml). To investigate the importance of TLR4 in the signal pathway, a group, blocked by anti-TLR4 antibody before LPS stimulation, was added to theC3H/HeN mice sample.


RESULTS
In vitro, in C3H/HeN mice, Iris posterior synechia was found 24 h later. However, an inflammation reaction was not found in the anterior chamber of the C3H/HeJ mice. In cell culture, TLR4 expression was observed in peritoneal macrophages of the C3H/HeN mice, both with and without LPS stimulation. TLR4 was primarily expressed in the membrane and no significant difference in inflorescence intensity (p=0.081) was found among the groups. MyD88 was expressed in the cytoplasm and the nucleus. There is statistical significance in the fluorescence intensity among groups of C3H/HeN mice (p<0.0001). NF-κB was primarily expressed in the cytoplasm before LPS stimulation. However, this occurred 1 h after LPS stimulation and could be observed in the nucleus. Three hours after LPS stimulation, the expression of NF-κB could not be detected in the cytoplasm or the nucleus. The fluorescence intensity of TLR4 and MyD88 expression showed no significant difference (p=0.113) between the anti-TLR4 antibody pretreatment group and the other groups of C3H/HeN mice. However, in the anti-TLR4 antibody pretreatment group, 1 h to 24 h after LPS stimulation, NF-κB only expressed in the cell membrane. Peritoneal macrophages from all groups of C3H/HeJ mice showed no obvious changes in morphology and size after LPS stimulation (p=0.257). TLR4 was primarily expressed in the cell membrane, and fluorescence intensity showed no statistical significance (p=0.228); MyD88 was expressed in the cytoplasm and the nucleus and there was no significant difference in fluorescence intensity among the groups (p=0.108); NF- κB was expressed in the cytoplasm, without LPS stimulation; however, 1 h after LPS stimulation, it appeared in the cell membrane and persisted until 24 h.


CONCLUSIONS
Acute anterior uveitis can be induced in wild-type mice, but it cannot be induced in TLR4 gene-deficient mice. The variation of expression of TLR4, and its downstream signal transduction molecules, MyD88 and NF-κB, after LPS stimulation in vitro, suppose the potential role of a TLR4-MyD88-dependent pathway in the pathogenesis of acute anterior uveitis. The blockage of this pathway by anti-TLR4 may signal a new direction in the treatment of acute anterior uveitis.
Department of Ophthalmology, Chaoyang Hospital, Capital Medical University, Beijing, China.
Jing
J
Wang
Hong
H
Lu
Xiaofeng
X
Hu
Wei
W
Chen
Zhuozai
Z
Xu
Shang
S
Li
Yingzhi
Y
Xu
D000208:Acute Disease; D000818:Animals; D002467:Cell Nucleus / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000378:metabolism; D008264:Macrophages / Q000378:metabolism; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008856:Microscopy, Fluorescence / Q000379:methods; D053594:Myeloid Differentiation Factor 88 / Q000378:metabolism*; D016328:NF-kappa B / Q000378:metabolism*; D021381:Protein Transport; D015398:Signal Transduction; D051197:Toll-Like Receptor 4 / Q000378:metabolism; D014606:Uveitis, Anterior / Q000378:metabolism*
D008070:Lipopolysaccharides; C507780:Myd88 protein, mouse; D053594:Myeloid Differentiation Factor 88; D016328:NF-kappa B; C493487:Tlr4 protein, mouse; D051197:Toll-Like Receptor 4
Immunol Res. 2007;39(1-3):249-60
17917069
J Immunol Methods. 2008 Jan 1;329(1-2):194-200
18036607
Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4186-91
15010525
Best Pract Res Clin Rheumatol. 2006 Jun;20(3):487-505
16777578
J Exp Med. 1999 Jun 7;189(11):1777-82
10359581
Surv Ophthalmol. 2005 Jul-Aug;50(4):364-88
15967191
J Immunol. 2000 Apr 1;164(7):3471-5
10725698
Expert Rev Mol Med. 2003 Jul 07;5(19):1-15
14585165
J Exp Med. 1986 Sep 1;164(3):777-93
2427635
J Exp Med. 1989 Oct 1;170(4):1231-41
2477488
Semin Immunol. 2007 Feb;19(1):3-10
17275324
Br J Ophthalmol. 1999 May;83(5):598-604
10216062
Br J Ophthalmol. 2006 Jan;90(1):103-8
16361678
Annu Rev Immunol. 2003;21:335-76
12524386
Cytokine. 2008 May;42(2):145-151
18304834
Blood Cells Mol Dis. 1998 Sep;24(3):340-55
10087992
Science. 1990 Sep 21;249(4975):1431-3
1698311
Mol Vis. 2009;15:619-28
19347047
Exp Eye Res. 1995 Nov;61(5):629-32
8654505
J Immunol. 2001 Aug 1;167(3):1609-16
11466383
Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1711-7
17389503
Nat Immunol. 2002 Jul;3(7):667-72
12055629
Int Immunol. 2005 Jan;17(1):1-14
15585605